TORISEL Side Effects

7039210-6 | Blood Glucose Increased, Disease Progression, Rash
on Jun 16, 2010 Female patient from UNITED STATES , 73 years of age, weighting 127.1 lb, was diagnosed with renal cancer and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, disease progression, rash (What is rash?). Torisel dosage: Intravenous.

7039185-X | Disease Progression
Patient was taking Torisel (View Usage). Patient had the following side effects: disease progression on Aug 02, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Torisel dosage: 25 Mg 1x Per 1 Wk, Intravenous.

7039175-7 | Disease Progression
Adverse event was reported on Jun 30, 2010 by a Male patient taking Torisel (View Usage) (Dosage: 25 Mg 1x Per 1 Wk, Intravenous) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , 61 years of age, After Torisel was administered, patient had the following side effects: disease progression.

7039174-5 | Oedema, Oedema Peripheral, Skin Tightness
on Jun 22, 2010 Female patient from UNITED STATES , weighting 142.1 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: oedema, oedema peripheral, skin tightness. Torisel dosage: 25 Mg 1x Per 1 Wk, Intravenous. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VITAMIN B12 (View Vitamin B12 Review and Vitamin B12 Label ).


7039145-9 | Anaphylactic Reaction, Back Pain, Nausea
on Jun 01, 2010 Male patient from UNITED STATES , weighting 186.2 lb, was diagnosed with renal cancer and was treated with Torisel (View Usage). Patient had the following side effects: anaphylactic reaction, back pain (What is back pain?), nausea (What is nausea?). Torisel dosage: . During the same period patient was treated with HYDROCODONE BITARTRATE + ACETAMINOPHEN (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), ROXICODONE (View Roxicodone Review and Roxicodone Label ), AMBIEN (View Ambien Review and Ambien Label ), MULTIVITAMINS (ASCORBIC ACID/ERGOCALCIFEROL/FOLIC ACID/NICOTINAMIDE/PA (View Multivitamins (ascorbic Acid/ergocalciferol/folic Acid/nicotinamide/pa Review and Multivitamins (ascorbic Acid/ergocalciferol/folic Acid/nicotinamide/pa Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

7039135-6 | Injection Site Extravasation
Patient was taking Torisel (View Usage). After Torisel was administered, patient had the following side effects: injection site extravasation on Jun 17, 2010 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 128.1 lb, was diagnosed with renal cancer and. Torisel dosage: Intravenous. During the same period patient was treated with DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

7018563-9 | Blood Creatinine Increased, Blood Urea Increased
Adverse event was reported on Sep 21, 2010 by a Female patient taking Torisel (View Usage) (Dosage: ) was diagnosed with renal cancer metastatic and. Location: UNITED STATES , weighting 180.2 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased. During the same period patient was treated with ACETAMINOPHEN AND OXYCODONE HCL (View Acetaminophen And Oxycodone Hcl Review and Acetaminophen And Oxycodone Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

7014124-6 | Anaemia, Pneumonia, Respiratory Failure
on Sep 22, 2010 Male patient from GERMANY , weighting 235.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Torisel (View Usage). Patient had the following side effects: anaemia, pneumonia (What is pneumonia?), respiratory failure. Torisel dosage: . During the same period patient was treated with CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ), VOLTAREN (12.5 Mg As Needed) (View Voltaren Review and Voltaren Label ), METOHEXAL (View Metohexal Review and Metohexal Label ), HCT (View Hct Review and Hct Label ). Patient was hospitalized.

7010342-1 | Leukopenia, Thrombocytopenia, Tonsillitis
on Sep 20, 2010 Male patient from GERMANY , 77 years of age, was diagnosed with mantle cell lymphoma, renal cell carcinoma and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: leukopenia, thrombocytopenia, tonsillitis. Torisel dosage: 175 Mg Every 1 Tot. Patient was hospitalized.

7008242-6 | Disease Progression
Patient was taking Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression on Sep 16, 2010 from FRANCE Additional patient health information: Female patient , 46 years of age, was diagnosed with metastatic renal cell carcinoma and. Torisel dosage: .

7004169-4 | Back Pain, Blood Pressure Increased, Hypersensitivity
Adverse event was reported on Feb 19, 2010 by a Male patient taking Torisel (View Usage) (Dosage: Received 2 Doses) . Location: UNITED STATES , weighting 150.1 lb, Patient had the following side effects: back pain (What is back pain?), blood pressure increased, hypersensitivity.

7003972-4 | Hyperglycaemia, Hyperlipidaemia
on Feb 19, 2010 Male patient from UNITED STATES , weighting 195.2 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: hyperglycaemia, hyperlipidaemia. Torisel dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (81 Mg Frequency Not Specified) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

7003802-0 | Hyperlipidaemia
on Jan 04, 2010 Male patient from UNITED STATES , weighting 178.2 lb, was diagnosed with renal cell carcinoma, pulmonary embolism (What is pulmonary embolism?) and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: hyperlipidaemia. Torisel dosage: . During the same period patient was treated with CLONAZEPAM (Not Provided) (View Clonazepam Review and Clonazepam Label ), ARIXTRA (View Arixtra Review and Arixtra Label ), LEXAPRO (Not Provided) (View Lexapro Review and Lexapro Label ), PEPCID (Not Provided) (View Pepcid Review and Pepcid Label ).

7003771-3 | Blood Cholesterol Increased, Blood Triglycerides Increased
Patient was taking Torisel (View Usage). Patient had the following side effects: blood cholesterol increased, blood triglycerides increased on Dec 14, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 174.2 lb, was diagnosed with renal cell carcinoma and. Torisel dosage: . During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), TRICOR (View Tricor Review and Tricor Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ZESTRIL (View Zestril Review and Zestril Label ), ZOCOR (View Zocor Review and Zocor Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

7000612-5 | Disease Progression
Adverse event was reported on Sep 16, 2010 by a Male patient taking Torisel (View Usage) (Dosage: ) was diagnosed with metastatic renal cell carcinoma and. Location: FRANCE , 65 years of age, After Torisel was administered, patient had the following side effects: disease progression.

6997961-3 | Dehydration, Fatigue, Hypokalaemia, Hypophosphataemia, Mucosal Inflammation, Musculoskeletal Pain
on Sep 14, 2010 Female patient from UNITED STATES , 75 years of age, weighting 170.4 lb, was diagnosed with ovarian cancer and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, fatigue, hypokalaemia, hypophosphataemia, mucosal inflammation, musculoskeletal pain. Torisel dosage: 25 Mg Over 30 Minutes On Days 1, 8, 15 And 22. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACTONEL (View Actonel Review and Actonel Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ), BEVACIZUMAB (10 Mg/kg Over 30 - 90 Minutes On Days 1 And 15) (View Bevacizumab Review and Bevacizumab Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6997940-6 | Cheilitis, Conjunctivitis, Eczema, Lymphopenia, Skin Burning Sensation
on Sep 14, 2010 Female patient from FRANCE , weighting 125.7 lb, was diagnosed with mantle cell lymphoma and was treated with Torisel (View Usage). Patient had the following side effects: cheilitis, conjunctivitis, eczema (What is eczema?), lymphopenia, skin burning sensation. Torisel dosage: . During the same period patient was treated with CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6997673-6 | Blood Creatinine Increased, Nephropathy Toxic
Patient was taking Torisel (View Usage). After Torisel was administered, patient had the following side effects: blood creatinine increased, nephropathy toxic on Nov 07, 2009 from UNITED STATES Additional patient health information: Male patient , 81 years of age, was diagnosed with renal cell carcinoma and. Torisel dosage: . During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), FLOMAX (View Flomax Review and Flomax Label ), HYDROCHLOROTHIAZIDE (12 .5 Mg (frequency Not Provided)) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6997533-0 | Haemoglobin Decreased, Hypoacusis, Oedema Peripheral, Onychoclasis
Adverse event was reported on Oct 22, 2009 by a Male patient taking Torisel (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , weighting 168.1 lb, Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, hypoacusis, oedema peripheral, onychoclasis. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), BENADRYL (View Benadryl Review and Benadryl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ).

6997095-8 | Infusion Site Extravasation
on Sep 02, 2009 Male patient from UNITED STATES , 82 years of age, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). Patient had the following side effects: infusion site extravasation. Torisel dosage: 25 Mg.

6997092-2 | Erythema, Oedema Peripheral, Rash Papular
on Nov 12, 2009 Male patient from UNITED STATES , weighting 186.2 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: erythema, oedema peripheral, rash papular. Torisel dosage: 25 Mg Every. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMILORIDE HYDROCHLORIDE (View Amiloride Hydrochloride Review and Amiloride Hydrochloride Label ), OSCAL (View Oscal Review and Oscal Label ), HYDROCODONE BITARTRATE + ACETAMINOPHEN (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

6992101-9 | Disease Progression
Patient was taking Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression on Sep 13, 2010 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with metastatic renal cell carcinoma and. Torisel dosage: .

6991392-8 | Groin Pain, Neuropathy Peripheral
Adverse event was reported on Jul 02, 2009 by a Male patient taking Torisel (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: groin pain, neuropathy peripheral.

6991379-5 | Oedema Peripheral
on Jul 09, 2009 Male patient from UNITED STATES , weighting 217.2 lb, was diagnosed with metastatic renal cell carcinoma, hyperglycaemia, electrolyte depletion and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: oedema peripheral. Torisel dosage: . During the same period patient was treated with ALDACTONE (Low Dose) (View Aldactone Review and Aldactone Label ), INSULIN (Blood Glucose In 300's) (View Insulin Review and Insulin Label ), HYDROCHLOROTHIAZIDE (Low Doses) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), POTASSIUM (View Potassium Review and Potassium Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ).

6991369-2 | Dermatitis, Erythema, Rash, Skin Hypertrophy
on Jun 01, 2009 Female patient from UNITED STATES , weighting 143.1 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis, erythema, rash (What is rash?), skin hypertrophy. Torisel dosage: . During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ), POTASSIUM (View Potassium Review and Potassium Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6991356-4 | Blood Creatinine Increased, Tremor
Patient was taking Torisel (View Usage). Patient had the following side effects: blood creatinine increased, tremor on Jul 30, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 110.1 lb, was diagnosed with metastatic renal cell carcinoma and. Torisel dosage: . During the same period patient was treated with VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ADVAIR DISKUS 100/50 (500/50 Mcg/dose Bid) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), DUONEB (View Duoneb Review and Duoneb Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VICODIN (5-500 Mg Tablet As Directed) (View Vicodin Review and Vicodin Label ), BENADRYL (View Benadryl Review and Benadryl Label ), ZOFRAN (100 Ml) (View Zofran Review and Zofran Label ).

6991355-2 | Back Pain, Chest Pain, Pain In Extremity
Adverse event was reported on Jun 04, 2009 by a Female patient taking Torisel (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , weighting 148.1 lb, After Torisel was administered, patient had the following side effects: back pain (What is back pain?), chest pain (What is chest pain?), pain in extremity. During the same period patient was treated with VITAMINS (Dose Not Provided, Frequency Once A Day) (View Vitamins Review and Vitamins Label ), ESTRADIOL (Frequency Once A Day, Dose Not Provided) (View Estradiol Review and Estradiol Label ).

6991345-X | Anaphylactic Reaction
on Jun 26, 2009 Male patient from UNITED STATES , 38 years of age, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Torisel dosage: 25 Mg.

6991333-3 | Fatigue, Neutropenia, Pyrexia
on Jul 30, 2009 Male patient from UNITED STATES , 73 years of age, weighting 190.2 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). Patient had the following side effects: fatigue, neutropenia, pyrexia. Torisel dosage: . During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ADVAIR DISKUS 100/50 (500/50 Bid) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), MAGNESIUM CHLORIDE ANHYDROUS (Mag 64 535 (64 Mg) Tablet, Controlled Release Bid) (View Magnesium Chloride Anhydrous Review and Magnesium Chloride Anhydrous Label ), KLOR CON (View Klor-con Review and Klor-con Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), XOPENEX (View Xopenex Review and Xopenex Label ), ATROPINE SULFATE/DIPHENOXYLATE (1 Tablet Every 1 Prn) (View Atropine Sulfate/diphenoxylate Review and Atropine Sulfate/diphenoxylate Label ).

6991310-2 | Blood Creatinine Increased, Blood Glucose Increased, Blood Urea Increased, Glomerular Filtration Rate Decreased, Haematocrit Decreased, Haemoglobin Decreased, Localised Oedema, Scrotal Oedema, White Blood Cell Count Decreased
Patient was taking Torisel (View Usage). After Torisel was administered, patient had the following side effects: blood creatinine increased, blood glucose increased, blood urea increased, glomerular filtration rate decreased, haematocrit decreased, haemoglobin decreased, localised oedema, scrotal oedema, white blood cell count decreased on Jul 15, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 202.2 lb, was diagnosed with renal cancer and. Torisel dosage: Once Weekly. Patient was hospitalized.

6985271-X | Hypertensive Crisis, Infusion Related Reaction, Pulmonary Oedema
Adverse event was reported on Sep 08, 2010 by a Male patient taking Torisel (View Usage) (Dosage: 25 Mg Per Infusion, Dose Scheme According To Study Protocol) was diagnosed with mantle cell lymphoma, hypertension, hypercholesterolaemia and. Location: GERMANY , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: hypertensive crisis, infusion related reaction, pulmonary oedema. During the same period patient was treated with RITUXIMAB (675 Mg Per Infusion, Dose Scheme According To Study Protocol) (View Rituximab Review and Rituximab Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

6983982-3 | Renal Failure
on Apr 14, 2009 Male patient from UNITED STATES , 59 years of age, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). Patient had the following side effects: renal failure. Torisel dosage: .

6983943-4 | Hair Colour Changes, Nausea, Vertigo, Weight Decreased
on Apr 20, 2009 Male patient from UNITED STATES , weighting 230.2 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: hair colour changes, nausea (What is nausea?), vertigo, weight decreased. Torisel dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), NORVASC (View Norvasc Review and Norvasc Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6983939-2 | Infusion Site Erythema, Infusion Site Extravasation, Infusion Site Swelling
Patient was taking Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: infusion site erythema, infusion site extravasation, infusion site swelling on May 19, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 112.1 lb, was diagnosed with renal cell carcinoma and. Torisel dosage: .

6983858-1 | Renal Failure Acute
Adverse event was reported on Apr 02, 2009 by a Female patient taking Torisel (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 210.2 lb, Patient had the following side effects: renal failure acute. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), INSULIN (View Insulin Review and Insulin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), ZANTAC (View Zantac Review and Zantac Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LOVAZA (View Lovaza Review and Lovaza Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6983848-9 | Metastasis
on Mar 18, 2009 Male patient from UNITED STATES , weighting 185.2 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: metastasis. Torisel dosage: .

6983838-6 | Infusion Site Extravasation, Injection Site Erythema, Injection Site Swelling
on Apr 08, 2009 Male patient from UNITED STATES , weighting 191.2 lb, was diagnosed with renal cell carcinoma and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: infusion site extravasation, injection site erythema, injection site swelling. Torisel dosage: . During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), METAMUCIL 2 (View Metamucil-2 Review and Metamucil-2 Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CALCIUM CARBONATE/VITAMIN D (View Calcium Carbonate/vitamin D Review and Calcium Carbonate/vitamin D Label ).

6983837-4 | Extravasation
Patient was taking Torisel (View Usage). Patient had the following side effects: extravasation on Apr 21, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 147.1 lb, was diagnosed with metastatic renal cell carcinoma, erythema, pruritus and. Torisel dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), VICODIN (View Vicodin Review and Vicodin Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), MEDROL (^as Directed^) (View Medrol Review and Medrol Label ), ATIVAN (View Ativan Review and Ativan Label ).

6983808-8 | Dizziness, Flushing, Injection Site Erythema, Injection Site Warmth
Adverse event was reported on Apr 14, 2009 by a Male patient taking Torisel (View Usage) (Dosage: ) was diagnosed with renal cancer metastatic and. Location: UNITED STATES , weighting 150.1 lb, After Torisel was administered, patient had the following side effects: dizziness (What is dizziness?), flushing, injection site erythema, injection site warmth.

6980063-X | Disease Progression
on Sep 10, 2010 Male patient from FRANCE , 62 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression. Torisel dosage: .

6980062-8 | Disease Progression
on Sep 10, 2010 Female patient from FRANCE , 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Torisel (View Usage). Patient had the following side effects: disease progression. Torisel dosage: .

6980061-6 | Disease Progression
Patient was taking Torisel (View Usage). After Torisel was administered, patient had the following side effects: disease progression on Sep 10, 2010 from FRANCE Additional patient health information: Female patient , 40 years of age, was diagnosed with metastatic renal cell carcinoma and. Torisel dosage: .

6980060-4 | Disease Progression
Adverse event was reported on Sep 10, 2010 by a Male patient taking Torisel (View Usage) (Dosage: ) was diagnosed with metastatic renal cell carcinoma and. Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: disease progression.

6980058-6 | Disease Progression, Metastatic Renal Cell Carcinoma
on Sep 10, 2010 Male patient from FRANCE , 62 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Torisel (View Usage). Patient had the following side effects: disease progression, metastatic renal cell carcinoma. Torisel dosage: .

6980057-4 | Disease Progression
on Sep 10, 2010 Female patient from FRANCE , 53 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: disease progression. Torisel dosage: .

6979937-5 | Blood Creatinine Abnormal, Dehydration, Dyspnoea, Fatigue, Muscular Weakness
Patient was taking Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine abnormal, dehydration, dyspnoea, fatigue, muscular weakness on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 161.2 lb, was diagnosed with metastatic renal cell carcinoma and. Torisel dosage: 25 Mg, Days 1, 8, 15, 22 Every 28 Days, Total Dose Administered This Course 75 Mg. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), COMPAZINE (View Compazine Review and Compazine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ATIVAN (View Ativan Review and Ativan Label ), BEVACIZUMAB (10 Mg/kg, Day 1, 15, Total Dose Administered This Course 1515 Mg) (View Bevacizumab Review and Bevacizumab Label ), HYDRODIURIL (View Hydrodiuril Review and Hydrodiuril Label ). Patient was hospitalized.

6977927-X | Disease Progression
Adverse event was reported on Sep 07, 2010 by a Male patient taking Torisel (View Usage) (Dosage: ) was diagnosed with metastatic carcinoid tumour and. Location: CANADA , 16 years of age, Patient had the following side effects: disease progression.

6977228-X | Disease Progression
on Sep 08, 2010 Male patient from BELGIUM , 64 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Torisel (View Usage). After Torisel was administered, patient had the following side effects: disease progression. Torisel dosage: .

6977225-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Abnormal, Blood Alkaline Phosphatase Abnormal, Condition Aggravated, Cough, Dry Skin, Dysphonia, Headache, Malaise
on Aug 28, 2010 Female patient from HONG KONG , 39 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Torisel (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase abnormal, blood alkaline phosphatase abnormal, condition aggravated, cough, dry skin, dysphonia, headache (What is headache?), malaise. Torisel dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6977132-7 | Abdominal Pain, Multi-organ Failure, Nausea, Renal Failure Acute
Patient was taking Torisel (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), multi-organ failure, nausea (What is nausea?), renal failure acute on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with hepatic neoplasm malignant and. Torisel dosage: 25 Mg Days 1, 8, 15 And 22. During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), BEVACIZUMAB (10 Mg/kg Over 30 - 90 Minutes On Days 1 And 15) (View Bevacizumab Review and Bevacizumab Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.